Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for AViTA Corporation (4735:TWSE), powered by AI.
AViTA Corporation is currently trading at $31.75. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for AViTA Corporation on Alpha Lenz.
View AViTA Corporation's valuation metrics on Alpha Lenz.
“AViTA Corporation's ROE is 10.2%. Explore profitability and growth together.”
Ask for details →AViTA Corporation is a healthcare equipment manufacturer specializing in home medical devices. Established in 1996 and headquartered in New Taipei City, Taiwan, the company develops, produces, and distributes a diverse range of personal health monitoring products. Its portfolio features non-contact and infrared ear/forehead thermometers, arm and wrist type blood pressure monitors, electronic lice combs, nasal aspirators, pulse oximeters, nebulizers, and tubeless blood pressure monitors. AViTA's offerings are designed to support at-home patient monitoring, making routine health checks accessible and user-friendly for consumers. The company serves both the domestic Taiwanese market and international clients, emphasizing export activities. By focusing on digital and point-of-care technology, AViTA plays an integral role in advancing the accessibility of preventive health tools, particularly within the broader healthcare equipment and supplies sector. Its commitment to product innovation and global distribution positions AViTA as a significant contributor to the expanding landscape of personal healthcare solutions.
“AViTA Corporation's ROE is 10.2%. Explore profitability and growth together.”
Ask for details →AViTA Corporation (ticker: 4735) is a company listed on TWSE in the Healthcare sector (Medical Devices).
The current price is 31.75 with a P/E ratio of -x and P/B of -x.
ROE is 10.16% and operating margin is 4.95%. Annual revenue is $936M.